Those who have heart failure with reduced ejection fraction (HFrEF) are typically treated with renin-angiotensin system inhibitors (ACE inhibitors, ARBs, or angiotensin receptor-neprilysin inhibitors [ARNIs]) whether or not they have albuminuria, since these drugs reduce mortality and morbidity in the setting of HFrEF.